Treatment Indications: correction of deep wrinkles (including nasolabial folds and marionette lines),, volume restoration in areas with significant tissue depression,, facial contouring (cheeks, chin, jawline).
Release form: 1 × 1.1 mL pre-filled syringe
Compound: cross‑linked hyaluronic acid (HA) of non‑animal origin (HTL, France), produced via biofermentation; crosslinking agent — BDDE (1,4‑butanediol diglycidyl ether); includes lidocaine HCl.
Concentration of GC: 24 mg/mL.
Lidocaine: 0.3%
Indications: deep dermal to subcutaneous injection for smoothing pronounced folds, restoring lost volume, and creating defined facial contours; suitable for areas requiring a high‑density, stable filler.